Considering that DM patients are at a higher risk of mortality from COVID-19, and diabetes mellitus is characterized by EAT inflammation in ACE-deficient conditions [7], we suspect that the relatively low plasma ACE2 level might promote a surge inflammation and subsequent organ dysfunction following SARS-CoV-2 infection. This evidence concerns the gene ACE2 and diabetes mellitus.